A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Status:
Recruiting
Trial end date:
2026-05-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to
placebo in participants with generalized myasthenia gravis (gMG).